MentionFox
Home › funding signals › Land Therapeutics Inc.
Form D · on the record

Land Therapeutics Inc. — $17.51M Form D filing, October 2026

Land Therapeutics Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-10-21.

Land Therapeutics Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 21, 2026. The filing reports $17.51M sold. Its industry group is Pharmaceuticals. It names Tony Ho (Executive Officer, Director), Rob Hopfner (Director), Timothy Shannon (Director) (SEC Form D/A, October 21, 2026).

Sell to companies like Land Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on Land Therapeutics Inc. →

Land Therapeutics Inc.

New Form D on file · 2026-10-21 · the record

$17.51M
raise on the record
D/A
filing
12
investors in
MASSACHUSETTS
based
Open the record →

What the record says

FilingForm D/A (amended)
Filed2026-10-21
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedCHARLESTOWN, MASSACHUSETTS
CIK2051104
Accession0002051104-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Land Therapeutics Inc.

Watch Land Therapeutics Inc.

Free to see. No signup.

What do you want to do with Land Therapeutics Inc.?

Get the full cited report on Land Therapeutics Inc.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Land Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $92,111,706. Sold: $17,511,614. Left to sell: $74,600,092. (filing)
  • Investors: 12 had already invested. (filing)
  • Date of first sale: December 23, 2024. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Total amount sold includes $911,624.12 of cancellation of indebtedness and $16,599,989.86 of new cash.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Land Therapeutics Inc. See pricing

Filing history · 2 filings on this registrant
Form D · 2025-01-07 · $16.91MForm D/A, amended · 2026-10-21 · $17.51M · this page 2025-01-07 2026-10-21

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Pharmaceuticals · by week
This raise, $17.51M, filed week of Oct 19

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $17.51M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Land Therapeutics Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Land Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Land Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Land Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Land Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

Land Therapeutics Inc.: Raised $17.51M, Form D filed 2026-10-21

Cite this page

Permanent URL: https://mentionfox.com/funding/land-therapeutics-inc-form-d-000003
Last updated 2026-10-22
Primary record: SEC filing 1 · SEC filing 2
Land Therapeutics Inc. raised $17.51M — SEC Form D filing, October 2026. MentionFox, 2026-10-22. https://mentionfox.com/funding/land-therapeutics-inc-form-d-000003